Home › Chronic Myeloid Leukemia

Chronic Myeloid Leukemia clinical trials recruiting in the U.S.

48 studies for Chronic Myeloid Leukemia are recruiting participants at sites across the United States.

Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.

Cities with the most studies

• Houston, TX18 studies
• Seattle, WA11 studies
• New York City, NY11 studies
• Philadelphia, PA6 studies
• Detroit, MI6 studies
• Chicago, IL6 studies
• Portland, OR6 studies
• Baldwin Park, CA6 studies
• Birmingham, AL6 studies
• Milwaukee, WI5 studies
• Durham, NC5 studies
• Baltimore, MD5 studies
• Columbus, OH5 studies
• Boston, MA5 studies
• Nashville, TN5 studies
• Cincinnati, OH4 studies
• Washington, DC4 studies
• Mountain View, CA4 studies
• Edison, NJ4 studies
• Atlanta, GA4 studies
• St. Louis, MO4 studies
• Kansas City, MO4 studies
• Augusta, GA4 studies
• Rochester, NY4 studies
• Aurora, CO3 studies
• Orange, CA3 studies
• Buffalo, NY3 studies
• Salt Lake City, UT3 studies
• Greenville, NC3 studies
• Minneapolis, MN3 studies
• Ann Arbor, MI3 studies
• St. Petersburg, FL3 studies
• Sacramento, CA3 studies
• Bridgeport, CT3 studies
• Miami, FL3 studies
• Cleveland, OH3 studies

By state

• Alabama6 studies
• Arizona4 studies
• California10 studies
• Colorado4 studies
• District of Columbia3 studies
• Florida7 studies
• Georgia6 studies
• Illinois6 studies
• Indiana3 studies
• Kansas5 studies
• Kentucky3 studies
• Maryland6 studies
• Massachusetts5 studies
• Michigan7 studies
• Minnesota4 studies
• Missouri4 studies
• Nebraska3 studies
• New Jersey4 studies
• New York15 studies
• North Carolina8 studies
• Ohio9 studies
• Oregon6 studies
• Pennsylvania7 studies
• Tennessee5 studies
• Texas18 studies
• Utah3 studies
• Virginia4 studies
• Washington11 studies
• Wisconsin5 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.